Took a day longer than i expected for mine.
Printable View
Took a day longer than i expected for mine.
Just hit the $1 mark again, hope it closes there or above that today :t_up:
As one who attended the meeting and is guided by FA rather than TA, I'd have to fully agree with Winner. The Aussie market for dairy and infant formula investment is obviously being driven by its own slightly crazy dynamics at present and anything is possible. One thing I took out of the meeting was the increased emphasis on IP and research, which pleased me. And although the general tone was fairly low-key despite the 2016 result upgrade I got the impression that future progress results (which will be issued quarterly because things are moving so fast) will be no disappointment.
"VIP membership cards for A2 fesh milk, CNY 1,920 for six months for 48 bottles"
"CNY 40/liter re A$8.80/L"
http://item.jd.com/1199167.html
http://item.jd.com/1625133.html
http://www.scoop.co.nz/stories/BU151...ro-a2-milk.htm
Another takeover looming???
Excerpts from the article above as per Mark Lister of Craigs.
"
Lister said a2 could be a takeover target in the future after batting away a bid earlier this year."It would arguably fit quite nicely into the portfolio of a larger player," he said.
I would very much doubt that. It's the kind of speculative comment that is sometimes tossed around by people who don't understand that A2 isn't just an alternative brand of milk that would make a nice addition to some company's product range. The entire a2 business is based firmly on a scientific proposition that is rejected and seen as a threat by the rest of the global dairy sector, namely that the standard bovine milk sold round the world contains a protein (a1) that is indigestible and/or medically hazardous to many consumers.
The growth of the a2 business will gradually and inevitably bring it into more direct conflict with the rest of the dairy sector as more scientific findings emerge. Therefore it doesn't fit into the portfolio of any mainstream dairy player, which raises the question, who else would be interested in it?
One of the positives to emerge from the recent rise in the a2MC share price is that it pretty much puts it out of the question as a takeover target (the offer would have to be around $1bn minimum), and secures a2MC's capability to stand on its own. That doesn't exclude the possibility that an outside company might be interested in taking a substantial stake in a2MC, especially now that Freedom Foods is no longer a 20% holder.
No shortage of Healthcare product companies outside the dairy companies there NT. Blackmores $3 Bill mkt cap,and Ebos $2 Bill plus(have already taken out someone bigger than them i think) , just two in our backyard.